Related references
Note: Only part of the references are listed.KRAS p.G13D Mutation and Codon 12 Mutations Are Not Created Equal in Predicting Clinical Outcomes of Cetuximab in Metastatic Colorectal Cancer A Systematic Review and Meta-Analysis
Chen Mao et al.
CANCER (2013)
BRAF mutations in melanoma and colorectal cancer: A single oncogenic mutation with different tumour phenotypes and clinical implications
F. Sclafani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features
Reetesh K. Pai et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Influence of KRAS Mutation Status in Metachronous and Synchronous Metastatic Colorectal Adenocarcinoma
Jeffrey S. Rose et al.
CANCER (2012)
BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
Amanda I. Phipps et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2012)
Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma
L. C. Krol et al.
EUROPEAN JOURNAL OF CANCER (2012)
Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients
Cristina Bozzao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients
I. Rako et al.
NEOPLASMA (2012)
Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma
Sarita B. Bagadi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
T. Yokota et al.
BRITISH JOURNAL OF CANCER (2011)
Impact of BRAF Mutation and Microsatellite Instability on the Pattern of Metastatic Spread and Prognosis in Metastatic Colorectal Cancer
Ben Tran et al.
CANCER (2011)
Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAFV600E mutation
Jeanne Tie et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
Timothy J. Price et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer
Ola Marzouk et al.
Cancers (2011)
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
A. Farina-Sarasqueta et al.
ANNALS OF ONCOLOGY (2010)
Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study
Adam Naguib et al.
BMC CANCER (2010)
Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal Cancer
Laura S. Rozek et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Is BRAF Mutation Associated with Interval Colorectal Cancers?
Aasma Shaukat et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery
Sabine Tejpar et al.
ONCOLOGIST (2010)
Microsatellite Instability, MLH1 Promoter Methylation, and BRAF Mutation Analysis in Sporadic Colorectal Cancers of Different Ethnic Groups in Israel
Alex Vilkin et al.
CANCER (2009)
BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients
Pei Woon Ang et al.
CANCER LETTERS (2009)
Somatic alterations, metabolizing genes and smoking in rectal cancer
Karen Curtin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype
Dallas R. English et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer
Amy J. French et al.
CLINICAL CANCER RESEARCH (2008)
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
Ludovic Barault et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer
Salvatore Artale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer
Tanya K. Kadiyska et al.
CANCER DETECTION AND PREVENTION (2007)
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer
Wade S. Samowitz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers
WS Samowitz et al.
CANCER RESEARCH (2005)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Share Paper
